blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2569320

EP2569320 - (+)-3-HYDROXYMORPHINAN-BASED POLYCYCLE DERIVATIVES AS NEUROPROTECTANTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.05.2015
Database last updated on 18.09.2024
Most recent event   Tooltip01.05.2015Application deemed to be withdrawnpublished on 03.06.2015  [2015/23]
Applicant(s)For all designated states
Green Cross Corporation
303 Bojeong-dong Giheung-gu
Yongin-si Gyeonggi-do 446-770 / KR
[2013/12]
Inventor(s)01 / LEE, Jinhwa
303 Bojeong-dong
Giheung-gu
Yongin-si Gyeonggi-do 446-770 / KR
02 / KIM, Jong Yup
303 Bojeong-dong
Giheung-gu
Yongin-si Gyeonggi-do 446-770 / KR
03 / KIM, Jeongmin
303 Bojeong-dong
Giheung-gu
Yongin-si Gyeonggi-do 446-770 / KR
04 / AHN, Kwang Woo
303 Bojeong-dong
Giheung-gu
Yongin-si Gyeonggi-do 446-770 / KR
 [2013/12]
Representative(s)Towler, Philip Dean
Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [2013/12]Towler, Philip Dean
Dehns St Bride's House 10 Salisbury Square London
EC4Y 8JD / GB
Application number, filing date11780837.813.05.2011
WO2011KR03548
Priority number, dateUS20100334371P13.05.2010         Original published format: US 334371 P
[2013/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011142620
Date:17.11.2011
Language:EN
[2011/46]
Type: A2 Application without search report 
No.:EP2569320
Date:20.03.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 17.11.2011 takes the place of the publication of the European patent application.
[2013/12]
Search report(s)International search report - published on:KR18.05.2012
(Supplementary) European search report - dispatched on:EP13.02.2014
ClassificationIPC:C07D498/08, C07D491/08, C07D471/08, A61K31/5386, A61P25/28, A61P25/16
[2014/12]
CPC:
C07D498/08 (EP,KR,US); A61K31/5386 (KR); A61P25/00 (EP);
A61P25/16 (EP); A61P25/28 (EP); C07D471/08 (EP,US);
C07D491/08 (EP,KR,US) (-)
Former IPC [2013/12]C07D498/08, C07D491/08, A61K31/5386, A61P25/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/12]
TitleGerman:POLYZYKLISCHE DERIVATE AUF (+)-3-HYDROXYMORPHINAN-BASIS ALS NEUROPROTEKTIVA[2013/12]
English:(+)-3-HYDROXYMORPHINAN-BASED POLYCYCLE DERIVATIVES AS NEUROPROTECTANTS[2013/12]
French:DÉRIVÉS POLYCYCLIQUES À BASE DE (+)-3-HYDROXYMORPHINANE EN TANT QUE NEUROPROTECTEURS[2013/12]
Entry into regional phase11.12.2012National basic fee paid 
11.12.2012Search fee paid 
11.12.2012Designation fee(s) paid 
11.12.2012Examination fee paid 
Examination procedure11.12.2012Examination requested  [2013/12]
08.08.2013Amendment by applicant (claims and/or description)
16.09.2014Application deemed to be withdrawn, date of legal effect  [2015/23]
02.12.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/23]
Fees paidRenewal fee
22.05.2013Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.05.201404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AP]WO2011014003  (GREEN CROSS CORP [KR], et al) [AP] 1-12 * the whole document * * in particular the examples *
 [AD]  - WEI ZHANG ET AL, "3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US, (20061201), vol. 20, no. 14, doi:10.1096/FJ.06-6006COM, ISSN 0892-6638, pages 2496 - 2511, XP008118601 [AD] 1-12 * the whole document * * in particular page 2496 *

DOI:   http://dx.doi.org/10.1096/fj.06-6006com
 [A]  - ZHANG A ET AL, "Synthesis of aminothiazole derived morphinans", TETRAHEDRON LETTERS, PERGAMON, GB, (20030818), vol. 44, no. 34, doi:10.1016/S0040-4039(03)01560-0, ISSN 0040-4039, pages 6459 - 6462, XP004442775 [A] 1-12 * the whole document * * in particular page 6459 and scheme 2 *

DOI:   http://dx.doi.org/10.1016/S0040-4039(03)01560-0
International search[A]US2008234307  (SCHUETZ JOHANNES [AT], et al);
 [A]US2009203723  (INAGAKI MASANAO [JP], et al);
 [A]US2006063792  (DOLLE ROLAND E [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.